Search
SOLACI Congress
HomeFile

File

View Category
Structural heart disease

One-Year Mortality Trends Following TAVR: STS/ACC TVT Registry Outcomes

Transcatheter aortic valve replacement (TAVR) has quickly consolidated as a safe and effective treatment option for patients...
Dr. Andrés Rodríguez -
Learn More
Arterial Accesses

Hyper-Adducted Right Radial Access vs. Left Radial Access: Aiming for Lower Daily Radiation Exposure

Interventional cardiologists face one of the most extreme occupational hazards: ionizing radiation. The right radial access (RRA)...
Dr. Omar Tupayachi -
Learn More
Structural heart disease

Is Transcarotid Access a Safe Option in TAVI?

Transcatheter aortic valve implantation (TAVI) should preferably be conducted via transfemoral access, according to European guideline (in...
Dr. Carlos Fava -
Learn More
Chronic Ischemic cardiopathy

Fasting versus No Fasting Before Percutaneous Cardiovascular Procedures

While the American Society of Anesthesiologists guidelines were updated in 2017 to allow for the intake of...
Dr. Juan Manuel Pérez -
Learn More
Chronic Ischemic cardiopathy

Smoking and Its Impact on Cardiovascular Disease 10 Years After Coronary Angioplasty

Smoking is a well-established risk factor for atherosclerotic cardiovascular diseases. However, some historical reports have suggested a...
Dr. Andrés Rodríguez -
Learn More
Pulmonary Valve

Endovascular Therapy for PE: Earlier Rather than Later Treatment, as in MI and Stroke?

Patients with pulmonary embolism (PE), whether intermediate-high or high risk, may progress to right ventricular (RV) dysfunction,...
Dr. Omar Tupayachi -
Learn More
Structural heart disease

5th Generation Balloon Expandable Valve in a Real World US Population: One-Year Outcomes

Transcatheter aortic valve replacement (TAVR) has consolidated as treatment for severe symptomatic aortic stenosis, even in low...
Dr. Andrés Rodríguez -
Learn More
Mitral valve

Percutaneous Treatment of Atrial Functional Mitral Regurgitation

Atrial functional mitral regurgitation (aFMR), which results from atrial dilation without significant left ventricular dysfunction, accounts for...
Dr. Carlos Fava -
Learn More

SOLACI is the reference organization for Latin American cardiovascular interventionism.

Last News

Transapical TMVR in High Risk Patients: Intrepid 5-Year Outcomes

Dr. Omar Tupayachi - 0
Moderate to severe mitral valve regurgitation (MR) continues is still a high prevalence condition with bad prognosis, particularly among the elderly with left ventricular...

EMERALD II: Non-Invasive Coronary Anatomy and Physiology (CCTA) in ACS Prediction

Dr. Omar Tupayachi - 0
Despite steady progress in secondary prevention and medical treatment optimization (OMT), acute coronary syndrome (ACS) remains one of the leading causes of cardiovascular morbimortality....

Impact of Balloon Post-Dilation on the Long-Term Durability of Bioprostheses after TAVR

Dr. Juan Manuel Pérez - 0
Balloon post-dilation (BPD) during transcatheter aortic valve replacement (TAVR) allows for the optimization of prosthesis expansion and the reduction of residual paravalvular aortic regurgitation....

Institutional News

SOLACI Wishes You Happy Holidays

solaci - 0
From the heart, Happy Holidays! The Latin American Society of Interventional Cardiology wishes all its members and the medical community across the continent a very Merry Christmas...

Condolences on the passing of Cristiam Arancibia

solaci - 0
The Latin American Society of Interventional Cardiology deeply mourns the passing of Lic. Cristiam Arancibia, first Director of the Chapter of Technicians and Nurses,...

Watch Again: Pulmonary Embolism in 2025 — Risk Stratification and Novel Therapeutic Approaches

solaci - 0
Our webinar “Pulmonary Embolism in 2025: Risk Stratification and Novel Therapeutic Approaches” is now available to watch. The session took place on November 25,...

Access

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Terms of Use -Privacy Policy